CareDx, Inc
Simbolis: CDNA
NASDAQ
10.32
USDRinkos kaina šiandien
-2.5757
P/E santykis
-0.0846
PEG koeficientas
534.35M
MRK kapitalizacija
- 0.00%
DIV pajamingumas
CareDx, Inc (CDNA) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1072.21 | 235.4 | 293.1 | 348.5 | ||||||||||||
balance-sheet.row.short-term-investments | 751.59 | 153.2 | 203.2 | 0 | ||||||||||||
balance-sheet.row.net-receivables | 213.69 | 51.1 | 66.3 | 59.8 | ||||||||||||
balance-sheet.row.inventory | 74.31 | 19.5 | 19.2 | 17.2 | ||||||||||||
balance-sheet.row.other-current-assets | 30.91 | 7.8 | 9.2 | 7.9 | ||||||||||||
balance-sheet.row.total-current-assets | 1391.12 | 313.7 | 387.8 | 433.4 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 268.6 | 65.1 | 70.2 | 40 | ||||||||||||
balance-sheet.row.goodwill | 159.81 | 40.3 | 37.5 | 37 | ||||||||||||
balance-sheet.row.intangible-assets | 181.32 | 45.7 | 43.1 | 50.2 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 341.14 | 86 | 80.6 | 87.2 | ||||||||||||
balance-sheet.row.long-term-investments | 2.27 | 0.6 | 0.5 | 0.2 | ||||||||||||
balance-sheet.row.tax-assets | 16.1 | 17.8 | 17.9 | 11.5 | ||||||||||||
balance-sheet.row.other-non-current-assets | 9.6 | 1.4 | -14 | -5.7 | ||||||||||||
balance-sheet.row.total-non-current-assets | 637.71 | 170.9 | 155.1 | 133.3 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 2028.83 | 484.6 | 543 | 566.6 | ||||||||||||
balance-sheet.row.account-payables | 44.59 | 12.9 | 9.9 | 13.3 | ||||||||||||
balance-sheet.row.short-term-debt | 23.45 | 5.9 | 5.6 | 4 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.long-term-debt-total | 120.13 | 28.3 | 33.4 | 17.4 | ||||||||||||
Deferred Revenue Non Current | 8.96 | 0 | -17.9 | 5.2 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 18.12 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 206.62 | 54.5 | 55.1 | 4.7 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 251.07 | 145.2 | 36.1 | 23.4 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 131.89 | 28.3 | 33.4 | 17.4 | ||||||||||||
balance-sheet.row.total-liab | 548.14 | 223.3 | 112.1 | 100.7 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0.2 | 0 | 0.1 | 0.1 | ||||||||||||
balance-sheet.row.retained-earnings | -2207.26 | -678.3 | -460.4 | -383.2 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -31.52 | -7 | -7.5 | -4.7 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3719.27 | 946.5 | 898.8 | 853.7 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 1480.7 | 261.3 | 430.9 | 465.9 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 2028.83 | 484.6 | 543 | 566.6 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-equity | 1480.7 | 261.3 | 430.9 | 465.9 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 2028.83 | - | - | - | ||||||||||||
Total Investments | 752.18 | 153.8 | 203.2 | 0.2 | ||||||||||||
balance-sheet.row.total-debt | 137.84 | 34.2 | 39 | 17.4 | ||||||||||||
balance-sheet.row.net-debt | -182.79 | -48 | -50.9 | -331.1 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -190.28 | -190.3 | -76.6 | -30.7 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 17.77 | 19.8 | 16 | 11.9 | ||||||||||||
cash-flows.row.deferred-income-tax | -1.84 | 0.6 | -0.2 | 4.1 | ||||||||||||
cash-flows.row.stock-based-compensation | 49.09 | 49.1 | 46.6 | 36.1 | ||||||||||||
cash-flows.row.change-in-working-capital | 106.11 | 106 | -14.2 | -41 | ||||||||||||
cash-flows.row.account-receivables | 16.02 | 16 | -6.7 | -24.4 | ||||||||||||
cash-flows.row.inventory | 0.05 | 0.1 | -2.9 | -6.9 | ||||||||||||
cash-flows.row.account-payables | 2.9 | 2.9 | -2.1 | 1.8 | ||||||||||||
cash-flows.row.other-working-capital | 87.14 | 87.1 | -2.6 | -11.4 | ||||||||||||
cash-flows.row.other-non-cash-items | 0.77 | -3.6 | 3.2 | 0.3 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -18.39 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -9.24 | -9.2 | -24.3 | -20.3 | ||||||||||||
cash-flows.row.acquisitions-net | -4.32 | -6.7 | -0.6 | -15.4 | ||||||||||||
cash-flows.row.purchases-of-investments | -202.13 | -201.2 | -315.1 | -5.5 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 256.04 | 256 | 111.6 | 88.9 | ||||||||||||
cash-flows.row.other-investing-activites | -0.87 | 1.5 | 0 | 0 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 40.45 | 40.4 | -228.5 | 47.7 | ||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | -0.1 | ||||||||||||
cash-flows.row.common-stock-issued | 1.16 | 1.6 | 2.4 | 188.9 | ||||||||||||
cash-flows.row.common-stock-repurchased | -27.54 | -27.5 | -0.6 | 2.1 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -2.1 | ||||||||||||
cash-flows.row.other-financing-activites | -3.23 | -3.7 | -6.3 | -3.1 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -29.61 | -29.6 | -4.5 | 185.6 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.11 | -0.1 | 0 | -0.3 | ||||||||||||
cash-flows.row.net-change-in-cash | -7.66 | -7.7 | -258.3 | 213.8 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 322.31 | 82.2 | 90.4 | 348.7 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 329.97 | 89.9 | 348.7 | 134.9 | ||||||||||||
cash-flows.row.operating-cash-flow | -18.39 | -18.4 | -25.2 | -19.3 | ||||||||||||
cash-flows.row.capital-expenditure | -9.24 | -9.2 | -24.3 | -20.3 | ||||||||||||
cash-flows.row.free-cash-flow | -27.63 | -27.6 | -49.6 | -39.6 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 280.32 | 280.3 | 321.8 | 296.4 | ||||||||||||
income-statement-row.row.cost-of-revenue | 102.64 | 104.5 | 112.2 | 97.4 | ||||||||||||
income-statement-row.row.gross-profit | 177.68 | 175.9 | 209.6 | 199 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 81.87 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 117.87 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 83.33 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 1.34 | 1.3 | -2.9 | -2.6 | ||||||||||||
income-statement-row.row.operating-expenses | 281.43 | 277.8 | 286.8 | 228.7 | ||||||||||||
income-statement-row.row.cost-and-expenses | 384.07 | 382.2 | 399 | 326.1 | ||||||||||||
income-statement-row.row.interest-income | 11.87 | 11.9 | 3.8 | 0.2 | ||||||||||||
income-statement-row.row.interest-expense | -0.45 | 0 | 3.8 | 0 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 83.33 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | -92.44 | -88.2 | 1 | -2.4 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 1.34 | 1.3 | -2.9 | -2.6 | ||||||||||||
income-statement-row.row.total-operating-expenses | -92.44 | -88.2 | 1 | -2.4 | ||||||||||||
income-statement-row.row.interest-expense | -0.45 | 0 | 3.8 | 0 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 12.99 | 19.8 | -0.1 | -0.1 | ||||||||||||
income-statement-row.row.ebitda-caps | -89.91 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | -104.59 | -101.9 | -77.2 | -29.7 | ||||||||||||
income-statement-row.row.income-before-tax | -190.14 | -190.1 | -76.2 | -32.1 | ||||||||||||
income-statement-row.row.income-tax-expense | 0.14 | 0.1 | 0.4 | -1.4 | ||||||||||||
income-statement-row.row.net-income | -190.28 | -190.3 | -76.6 | -30.7 |
Dažnai užduodami klausimai
Kas yra CareDx, Inc (CDNA) bendras turtas?
CareDx, Inc (CDNA) bendras turtas yra 484615000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra 132761000.000.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.634.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra -0.517.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra -0.679.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra -0.373.
Kas yra CareDx, Inc (CDNA) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra -190284000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 34221000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 277768000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 82197000.000.